RMD Resmed Earnings and EPS analysis

EPS in 2025 (TTM): $8.94

Last Report Period Date: Mar 31, 2025

Currently, RMD's 12-month EPS stands at $8.94, according to the most recent financial reports. Resmed's earnings per share in 2024 was reported at $6.94, marking a rise from $6.12 in 2023. RMD recorded an EPS of $2.49 for the quarterly period ending on Mar 31, 2025.

In 2024, Resmed's earnings per share was $6.94, a rise of 13.4% from $6.12 in 2023. The quarterly earnings per share for the period ending Mar 31, 2025, was $2.49, showing a 22.1% increase compared to the same quarter last year. The trailing twelve months EPS for RMD is $8.94 as of March 2025. Resmed's full-year EPS for 2023 was $6.12, a 14.6% rise compared to the previous year.

Resmed has recorded a growth in earnings per share of 22.1% over the past 12 months (YoY, quarterly). During the past three years, RMD had an average yearly EPS growth of 28.5%. Resmed had an average annual EPS growth of 19.7% in the last five years. Over the last decade, RMD had an average annual earnings per share growth of 11%.